New Key Statistics Module, Z-Score and F-Score
OTCPK:KYRNF Key Ratios
| Market Cap $ M | 628.82 |
| Enterprise Value $ M | 672.91 |
| P/E(ttm) | 18.63 |
| PE Ratio without NRI | 20.05 |
| Forward PE Ratio | -- |
| Price/Book | 0.76 |
| Price/Sales | 0.83 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 820.00 |
| EPS (TTM) $ | 0.64 |
| Beneish M-Score | -2.38 |
| 10-y EBITDA Growth Rate % | -4.40 |
| 5-y EBITDA Growth Rate % | -0.70 |
| y-y EBITDA Growth Rate % | 5.00 |
| EV-to-EBIT | 14.99 |
| EV-to-EBITDA | 14.99 |
| PEG | -- |
| Shares Outstanding M | 57.45 |
| Net Margin (%) | 4.45 |
| Operating Margin % | 5.03 |
| Pre-tax Margin (%) | 5.87 |
| Quick Ratio | 1.45 |
| Current Ratio | 2.62 |
| ROA % (ttm) | 3.02 |
| ROE % (ttm) | 4.20 |
| ROIC % (ttm) | 3.21 |
| Dividend Yield % | -- |
| Altman Z-Score | 3.65 |
KYRNF Number of Guru Trades
KYRNF Volume of Guru Trades
Gurus Latest Trades with OTCPK:KYRNF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:KYRNF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Kyorin Pharmaceutical Co Ltd Insider Transactions
No Available Data
News about OTCPK:KYRNF
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers